Advertise | AdChoices

New experimental HIV drug stalls early infection

Early-stage trial showed 95 percent reduction in the patients' viral load

Advertise | AdChoices

Text: We're sorry. The text content of this page is no longer available.

Discuss:

Discussion comments

“ ”

Expand Collapse
,
Reply
Advertise | AdChoices
Advertise | AdChoices
Advertise | AdChoices

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Related: AIDS

Advertise | AdChoices
  1. AIDS
    1. FDA panel backs at-home HIV test
    2. Bioethicist: At-home HIV test raises questions
    3. FDA reviews first rapid, take-home test for HIV
    4. FDA panel backs first pill to block HIV infection
    5. FDA review favors first drug for HIV prevention
  2. More health headlines
    1. A baby made in India: a couple's dream comes true
    2. Drastic method targets hard-to-treat hypertension
    3. Almost half of new vets seek disability
    4. Are we there yet? Road-trip tricks
    5. Kidney stone rate doubles in last 16 years
  3. Related videos and slideshows
    1. Video
      Notre Dame, Catholic groups challenge birth control rule
    2. Video
      How we should pay our doctor’s bill
    3. Video
      Family fights for autistic son to play baseball
    4. Video
      U.S. attorney general cracks down on Medicare fraud
  1. Jump to discussion

    New experimental HIV drug stalls early infection

  2. Jump to related

    AIDS